Note from the MOD:
1st if you would like to be an Asst MOD and feel you can follow the TOU regardless if you support this company or not, PM me. ALL VIEWS WILL BE REPRESENTED IN ACCORDANCE WITH IHUB RULES!
This board is to provide information on Hard to Treat Diseases (HTDS), almost all of the PR's that have been put out have been unverifiable so if you plan on buying shares thinking this is an investment in your future, I suggest you do some research first........Do you're DD.
HTDS is a holdco of a China based Shenzhen Mellow Hope Pharm Industrial Co.
Miro Zecevic and his companies.......... Including EMRY CAPITAL GROUP
Law Enforcement Agencies Launch Major Assault on Business Opportunity and Work-at-Home Scams
And Miro is one !!!! YES, THE SUPPOSED IR FOR HTDS!!!!!!
what is Caveat Emptor?
Buyer Beware. There is a public interest concern associated with the company, which may include a spam campaign, questionable stock promotion, known investigation of fraudulent activity committed by the company or insiders, regulatory suspensions, or disruptive corporate actions. During the time it is labeled Caveat Emptor, any stock that is not in the Current Information category will also have its quotes blocked on pinksheets.com.
MINAMAR DISCLAIMER:
Disclaimer: Never invest in any stock featured on our site, emails or press releases unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site. PLEASE NOTE: MMG and its employees are NOT registered as investment advisors in any jurisdiction whatsoever.
SOURCE Hard to Treat Diseases
-
Outstanding Shares
4,972,581,959 as of Mar 31, 2009
-
Authorized Shares
5,000,000,000 as of Mar 31, 2009
Contact Information
Hard to Treat Diseases, Inc.
2007 Shenzhen Mellow Hope Pharm
Room E-F, 12/F, Jinrun Mansion
No.6019 Shennan Blvd
Shenzen 518040
China
http://ih.advfn.com/p.php?pid=nmona&article=40954465&symbol=HTDS
Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million
Hard to Treat Diseases, Inc. (HTDS) Reports on Positive Research and HTDS MindUp Cancer Business Update
Mina Mar Group Expands Reward Program to Include an Amnesty Program
Hard to Treat Diseases Inc. (HTDS) Targets an EU Based Stem Cell Research Company for a Merger
Hard to Treat Diseases (HTDS) obtains H1N1 license with China SFDA
Hard to Treat Diseases, Inc. (HTDS) Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements
Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production
Hard To Treat Diseases (HTDS) to Retire Regulation D 504 Offering
Hard To Treat Diseases (HTDS.PK) Stem Cells and Regenerative Medicine
Hard To Treat Diseases (HTDS.PK) 50,000 doses of Mevac A To Sri Lanka
Hard To Treat Diseases (HTDS.PK) Stem Cell Graft Survival
Hard To Treat Diseases (HTDS.PK) Completes IP Ownership Filings With U.S. Patent and Trademark Office
Hard to Treat Diseases, Inc. (HTDS) TO Appoint Prof Mirjana Stojiljkovic As A Medical Advisor - Company Officer
Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS
Hard To Treat Diseases (HTDS.PK) Completes India Order
Hard To Treat Diseases (HTDS.PK) Reasserting Multi Million Dollar IP Ownership Rights
Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership
Hard to Treat Diseases, Inc. (HTDS) Finalizes Agreement with Yunnan Walvax Biotech
Hard to Treat Diseases, Inc. (HTDS) Reports on New Uses For Ribavirin
Hard To Treat Diseases (HTDS) Obtains HAS Certificate
http://www.htdsmedical.com/about.html